ArticleFrontiers in pharmacology2020

Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis.

Can Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.